NASDAQ:ICUI
Icu Medical Inc.
Icu Medical Inc.'s revenue fell 6.3% in fiscal 2025 to $2.2B while operating margin rose to 1.9%. Free cash flow was $91.8M, 4.1% of revenue, and the diluted share count rose 2.1%.Summary generated from Icu Medical Inc.'s SEC filings. Latest annual report filed Feb 19, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$2.2B
Revenue growth−6.3%
Revenue, 5-yr CAGR+11.9%
Gross margin36.8%
Operating margin1.9%
Net margin0.0%
ROIC0.7%
Return on equity0.0%
Debt / equity0.60
Free cash flow$91.8M
FCF margin4.1%
Share count change+2.1%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1,316 | 2,280 | 2,259 | 2,382 | 2,231 |
| Operating income | 123 | −43 | 23 | 43 | 43 |
| Net income | 103 | −74 | −30 | −118 | 1 |
| Free cash flow | 199 | −152 | 82 | 125 | 92 |
Recent filings
- 4Insider transaction report
Sep 3, 2026 - 4Insider transaction report
Sep 1, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KAmendment to articles or bylaws
May 18, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - DEF 14AProxy statement
Apr 2, 2026